Doherty Institute scientists first to grow and share Wuhan coronavirus
29 January 2020 Scientists from The Peter Doherty Institute for Infection and Immunity (Doherty Institute) in Melbourne have successfully grown the Wuhan coronavirus from a patient sample, which will provide expert international laboratories with crucial information to help…
Read MoreR&D tax set for Senate showdown
28 January 2020 By Denham Sadler, Senior Reporter Government cuts to the research and development tax incentive (RDTI) are set for a Senate showdown next week and is expected to be referred back to the same committee that rejected…
Read MoreMelbourne’s award-winning cancer treatment device
23 January 2020 Radiation oncology specialist, Chuan-Dong Wen has spent five years developing a device which is offering hope to cancer patients. He accepted the ‘Inspiration of the Year’ Award at the 26th National iAwards. by Georgina Jerums | 23 Jan…
Read MoreCSIRO to support nation’s bushfire rebuild
29 January 2020 CSIRO, Australia’s national science agency, has welcomed its role in delivering practical resilience measures in relation to bushfires and climate change, as the country faces continued extreme fire weather in the future. Announced by Prime…
Read MoreOn-shore commercial manufacture and wider subsidy for CAR T Cell therapy
28 January 2020 Peter Mac welcomes today’s announcements that will enable Australia’s first on-shore commercial manufacture of CAR T-Cell therapy, and lead to wider subsidised access to this treatment. Cell Therapies Pty Ltd, a company situated at Peter…
Read MoreGenetic drivers of myeloproliferative diseases revealed – WEHI
24 January 2020 Dr Melissa Call, Associate Professor Matthew Call, and Dr Jessica Bridgford led the study at the Walter and Eliza Hall Institute. Institute scientists have revealed seven new genetic mutations that cause myeloproliferative diseases – chronic…
Read MoreOne step closer to understanding cancer-fighting immune cells
23 January 2020 Researchers discover that protective immune cells are not created equally This article first appeared in Science in Public. Personalised treatment of cancers has moved one step closer, thanks to University of Melbourne researcher Dr Susan Christo. Increasingly,…
Read MoreMelbourne start-up Navi Medical Technologies receives $400,000 through Accelerating Commercialisation grant to develop pediatric medical device
30 January 2020 Navi Medical Technologies, a Melbourne based start-up company with ambitions to help critically ill newborns, has recently been awarded $396,452 in funding according to a recent media announcement from The Hon Karen Andrews MP, the Minister for Industry, Science…
Read MoreMelbourne – A Heartland City in a New Decade
30 January 2020 Poised for Rockstar status as a Science & Technology Biomedical cluster Every year the Global Innovation Index ranks the innovation performance of around 130 economies globally. The picture from the Global Innovation Index reflects that…
Read MoreAdoption and Diffusion of Disruptive Technologies:The Case of 3D Printing in the Medical Device Industry
28 January 2020 Australia has hosted several innovations in the 3D printed medical device industry, however widespread adoption and diffusion is quite low. This two-year project, funded by RMIT University provides analysis of the industry, its stakeholders (i.e. surgeons, patients,…
Read MoreImportance of acceptable use policy – IT Systems & Services
28 January 2020 An acceptable use policy (AUP) is a document stipulating constraints and practices that a user must agree to for access to a corporate network or the Internet. Many businesses and educational facilities require that employees…
Read MoreFirst product order from PMI and first patient treated in Germany
22 January 2020 PolyNovo has received its first orders of BTM from PMI for use in Germany, Austria and Switzerland. The first orders for NovoSorb BTM were shipped to hospitals in preparation for the first surgery. PolyNovo is…
Read More
